# Wuhan Hongren Biopharmaceutical Inc. – FDA Inspection, Sep 4, 2024

Source: https://www.keypedia.com/records/fda_inspections/wuhan-hongren-biopharmaceutical-inc/3d97762a-976d-4d9b-a61b-19099401db0d
Source feed: FDA_Inspections

> FDA inspection 1251337 of Wuhan Hongren Biopharmaceutical Inc., September 04, 2024. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251337
- Company Name: Wuhan Hongren Biopharmaceutical Inc.
- Inspection Date: 2024-09-04
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)

Company: https://www.keypedia.com/companies/wuhan-hongren-biopharmaceutical-inc/27dc633e-ae6d-4e67-b6a1-a5da5555215c

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8